Results 231 to 240 of about 1,149,461 (264)
Some of the next articles are maybe not open access.
The Cellular Basis of Tumor Progression
1997Variability in disease presentation and course is a hallmark of cancer. Variability is seen among similarly diagnosed cancers in different patients or animal hosts and in the same cancer at different periods of time. This latter type of variability, termed "tumor progression," was defined by Foulds in a series of six rules that describe the independent
G H, Heppner, F R, Miller
openaire +2 more sources
Tumor Progression and Catastrophe Theory
1993Progression is the development from bad to worse that is often observed in tumors. It can follow different courses, not only in different organs, but also in the same organ: sometimes there is a smooth, continuous progression from normal to malignant cells, sometimes suddenly a highly malignant tumor arises.
Daams, H. +3 more
openaire +2 more sources
HDAC6: Tumor Progression and Beyond
Current Cancer Drug TargetsHistone Deacetylase 6 (HDAC6) is an intriguing therapeutic target in cancer research, distinguished as the only HDAC family member predominantly located in the cytoplasm. HDAC6 features two catalytic domains and a unique ubiquitin-binding domain, which sets it apart from other HDACs.
Joao Marcos Oliveira-Silva +6 more
openaire +2 more sources
Tissue architecture in tumor initiation and progression
Trends in Cancer, 2022Jacco Van Rheenen +2 more
exaly
The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages
Frontiers in Oncology, 2022Lei Zhao, Yang Yong-Guang
exaly
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
Frontiers in Immunology, 2021Tao Xi, Xi Tao, Lufeng Zheng
exaly
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
International Journal of Molecular Sciences, 2020Sara Bravaccini +2 more
exaly
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
Journal of Experimental Medicine, 2020Gabriel A Rabinovich +2 more
exaly

